endoCRO

endoCRO is an Israeli contract research organization (CRO) and a subsidiary of iCAN: Israel-Cannabis, specializing in the clinical development and formulation of medical cannabis products. The company provides end-to-end services for the cannabis industry, including clinical trial management, regulatory consulting, and the development of advanced drug delivery systems such as eluting patches and suppositories. endoCRO collaborates with international pharmaceutical and biotech partners to bring standardized, GMP-grade cannabis therapeutics to market. Its expertise spans various therapeutic areas, including autoimmune diseases, neurology, and pain management, with a focus on bridging the gap between botanical research and pharmaceutical standards.